Although intranasal oxytocin is expected to be a novel therapy for the core symptoms of
autism spectrum disorder, which has currently no approved medication, the efficacy of …

Administration of oxytocin has been proposed as a treatment for the core symptoms of
autism spectrum disorder (ASD), including social-communicative deficit. Previous clinical …

Background There are no effective medications for the treatment of social cognition/function
deficits in autism spectrum disorder (ASD), and adult intervention literature in this area is …

The neuropeptide oxytocin has shown promise as a treatment for symptoms of autism
spectrum disorders (ASD). However, clinical research progress has been hampered by a …

Recent studies have suggested oxytocin as a possible drug to treat social deficits caused by
autism spectrum disorder (ASD), but the safety of intranasal oxytocin in autistic patients has …

Objective: Oxytocin (OT) has been a candidate for the treatment of autism spectrum
disorders (ASD), and the impact of intranasally delivered OT on ASD has been investigated …

Oxytocin is a potential therapeutic for the core symptoms of autism spectrum disorder (ASD),
which is currently untreatable with pharmacotherapy. Previous clinical trials of a single dose …

Background Intranasal administration of the “prosocial” neuropeptide oxytocin is
increasingly explored as a potential treatment for targeting the core characteristics of autism …

Intranasal administration of the neuropeptide oxytocin (OT) is increasingly explored as a
potential treatment for targeting the core symptoms of autism spectrum disorder (ASD) …

Extensive research efforts in the last decade have been expended into understanding
whether intranasal oxytocin may be an effective therapeutic in treating social communication …